Authors


Randall E. Scott, BS, CS

Latest:

Cutting through the Fog of Cloud Computing

More than one technology pundit has claimed that desktop software and computing that relies on local servers is on life support, soon to be replaced by an Internet-based approach that relies on a "cloud" of applications and virtual resources that are delivered over the Web via your browser. Are proponents who want to apply this concept to EMRs correct when they say that this is the future of health IT, or do they have their head in the clouds?



Brian Luster

Latest:

Estate Planning Essentials for Physicians

Planning can dramatically reduce-or avoid altogether-some common tax hits, including: capital gains, state, inheritance, and estate and gift taxes. There are several options to consider when building an estate plan.



Eric B. Gordon, MD

Latest:

CMS Proposed Changes to Medicare Graduate Medical Education Payments

On July 2, 2010, CMS released the proposed changes to the Medicare Outpatient Hospital Prospective Payment System for 2011.




Laura P. Svetkey, MD, MHS2

Latest:

Comprehensive lifestyle modification and blood pressure control

Lifestyle recommendations for the prevention and treatment of hypertension include weight loss, reduced sodium intake, increased physical activity, limited alcohol intake, and the Dietary Approaches to Stop Hypertension (DASH) diet. The 18-month results of the Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER) randomized clinical trial showed that individuals with prehypertension and stage 1 hypertension can make and sustain many of these lifestyle changes over the long term, thereby reducing their risk of cardiovascular disease.



Richard E. Stewart, MD, associate professor of medicine, Division of Cardiology, Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, Texas.

Latest:

Multislice computed tomography coronary angiography: A study in search of a clinical niche

The study presented in this issue of Cardiology Review by Schuijf and colleagues investigated various aspects of what is rapidly becoming an accepted imaging modality for the assessment of coronary artery disease.


Jeremy Slater, MD

Latest:

On Epilepsy, Insurers Should Follow Their Own Rhetoric on In-home Care

If CVS and Aetna are truly charting the future of healthcare in this country, then it’s long past-time that their actions align to their rhetoric.



Atsushi Yonemura, MD

Latest:

Lipid-lowering therapy and atherosclerotic aortic plaques

We showed that a significant reduction in thoracic aortic plaques and low-density lipoprotein cholesterol levels occurred after 12 months of treatment with atorvastatin. In the abdominal aorta, however, the change in atherosclerotic plaques correlated with age. These results show that plaques in the thoracic and abdominal aortas may respond differently to lipid-lowering therapy, and other factors, such as aging, may be more important for plaque progression in the abdominal aorta.




Wahida Karmally

Latest:

FCS Diet and Dangers

Wahida Karmally, MS, RD, CDE, explains the challenges and importance of diet in patients with familial chylomicronemia syndrome (FCS), how much fat can be eaten (and which kind), and the dangers of pancreatitis when too much fat is consumed.


Fran Lowry

Latest:

Experts Share Best Practice Tips for Managing Knee Osteoarthritis Pain

Non-surgical management options for osteoarthritis (OA) of the knee include low-impact exercise, physical therapy, and anti-inflammatories.


From Cabarrus Family Medicine, Concord, NC.

Latest:

Insulin as a strategy to optimize glycemic control in patients with type 2 diabetes

Treatment of type 2 diabetes should achieve and maintain euglycemia, thereby preventing complications from this progressive disease. Current antidiabetic therapies should be a part of a multimodal management program that includes diet, exercise, and blood pressure and lipid control. Oral antidiabetic drugs are still first-line therapy for type 2 diabetes, but intensification of therapy, including starting insulin, should occur every 2 to 3 months as needed to achieve euglycemia. The first insulin added is typically a basal insulin, which is effective in lowering fasting plasma glucose (FPG). A persistently elevated glycated hemoglobin (HgbA1C) level despite near or complete normalization of FPG, however, indicates postprandial hyperglycemia. In these cases, the addition of bolus insulin is required to reduce postprandial glucose (PPG). Several approaches to initiate and titrate insulin can be used based on FPG, PPG, HgbA1C, and patient factors.





Shu Yang, MD, Frank J. Domino, MD

Latest:

How Accurate are Cardiac Risk Calculators?

This prospective epidemiological study compares the capabilities of the new 2013 American Heart Association and American College of Cardiology ASCVD risk calculator against several alternative cardiovascular risk calculators and explores the potential effect of preventive therapy on risk overestimation in the AHA-ACC-ASCVD model.



Matt Hoffman & Kevin Kunzmann

Latest:

Suffering in Silence: The Scourge of Physician Suicide

Physician suicide is a taboo topic—and despite high rates of depression and PTSD among doctors, little help exists for those at risk.



Christian Firschke, MD

Latest:

Analysis of regional left ventricular function

We performed cineventriculography, unenhanced echocardiography, contrast-enhanced echocardiography, and magnetic resonance imaging to define the presence of regional left ventricular wall motion abnormalities. Interobserver agreement in the analysis of regional wall motion abnormality was highest for contrast-enhanced echocardiography, followed by cineventriculography and cardiac magnetic resonance imaging; it was lowest for unenhanced echocardiography. Contrast-enhanced echocardiography also showed the highest accuracy in the detection of panel-defined regional wall motion abnormalities.



Jamie Reiter, PhD

Latest:

ADA 2011: Ranibizumab Improves Visual Acuity in Patients with Diabetic Macular Edema

More patients in the RIDE and RISE trials treated with the VEGF inhibitor showed improvements in vision test scores compared to patients who received placebo.


John Otrompke

Latest:

Risk Factors Such as Male Gender, Residual Thrombosis, and High D-Dimer Suggest Patients with Pulmonary Embolism Should Consider Remaining on Oral Anticoagulants

One of the most important tasks for physicians treating a patient who has experienced a first unprovoked pulmonary embolism is determining how long the patient must remain on oral anticoagulants.


© 2024 MJH Life Sciences

All rights reserved.